Adenoviral pneumonia with organising features in an immunocompetent patient: When steroids make the difference

V Shrinath1, Ramakant Singh1, Anoop Kumar Nair2

  • 1Department of Medicine, INHS Asvini, Mumbai, Maharashtra, India.

Insights

Adenovirus pneumonia is rare in immunocompetent adults. This case report highlights an excellent response to corticosteroid therapy in a patient with severe adenovirus pneumonia and hypoxemic respiratory failure.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) is a leading cause of mortality and morbidity.
  • Adenovirus is a frequent cause of lower respiratory tract infections (LRTI) in children but rarely causes pneumonia in immunocompetent adults.
  • Limited medical literature and standardized therapies exist for adult adenovirus pneumonia.

Purpose of the Study:

  • To report a case of adenovirus pneumonia in an immunocompetent adult.
  • To evaluate the efficacy of ribavirin and corticosteroids in managing severe adenovirus pneumonia.
  • To highlight corticosteroids as a potential therapeutic option for severe adenovirus pneumonia.

Main Methods:

  • A case report of a 35-year-old immunocompetent woman with adenovirus pneumonia and hypoxemic respiratory failure.
  • Management included ribavirin and corticosteroids.
  • Clinical response to therapy was monitored.

Main Results:

  • The patient experienced hypoxemic respiratory failure due to adenovirus pneumonia.
  • She showed an excellent response to corticosteroid therapy.
  • Ribavirin was also administered, but the response to corticosteroids was particularly notable.

Conclusions:

  • Adenovirus pneumonia can occur in immunocompetent adults, presenting with severe respiratory compromise.
  • Corticosteroids may be a valuable therapeutic tool for managing severe cases of adenovirus pneumonia.
  • Further research is warranted to establish standardized treatment protocols for this rare condition.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...